Bioage Labs Inc (BIOA)
19.45
-0.72
(-3.57%)
USD |
NASDAQ |
Nov 14, 16:00
20.43
+0.98
(+5.04%)
After-Hours: 20:00
Bioage Labs Enterprise Value: 475.77M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 475.77M |
| November 12, 2024 | 470.52M |
| November 11, 2024 | 553.05M |
| November 08, 2024 | 538.21M |
| November 07, 2024 | 489.68M |
| November 06, 2024 | 561.40M |
| November 05, 2024 | 530.18M |
| November 04, 2024 | 549.96M |
| November 01, 2024 | 529.56M |
| October 31, 2024 | 581.80M |
| October 30, 2024 | 613.95M |
| October 29, 2024 | 629.71M |
| October 28, 2024 | 599.11M |
| October 25, 2024 | 596.02M |
| October 24, 2024 | 587.67M |
| October 23, 2024 | 584.89M |
| October 22, 2024 | 586.44M |
| October 21, 2024 | 650.73M |
| Date | Value |
|---|---|
| October 18, 2024 | 589.84M |
| October 17, 2024 | 562.94M |
| October 16, 2024 | 599.42M |
| October 15, 2024 | 609.62M |
| October 14, 2024 | 597.87M |
| October 11, 2024 | 523.07M |
| October 10, 2024 | 487.21M |
| October 09, 2024 | 471.75M |
| October 08, 2024 | 541.61M |
| October 07, 2024 | 538.52M |
| October 04, 2024 | 528.94M |
| October 03, 2024 | 497.10M |
| October 02, 2024 | 462.17M |
| October 01, 2024 | 478.25M |
| September 30, 2024 | 495.25M |
| September 27, 2024 | 501.43M |
| September 26, 2024 | 418.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
418.28M
Minimum
Sep 26 2024
650.73M
Maximum
Oct 21 2024
543.77M
Average
541.61M
Median
Oct 08 2024
Enterprise Value Benchmarks
| Eli Lilly and Co | 798.35B |
| Perspective Therapeutics Inc | 378.39M |
| Electromed Inc | 224.00M |
| Xtant Medical Holdings Inc | 92.99M |
| Myomo Inc | 136.14M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.58M |
| Total Expenses (Quarterly) | 15.27M |
| EPS Diluted (Quarterly) | -0.4393 |
| Earnings Yield | -9.12% |